Relationality and Ethics in MDMA-Assisted Therapy.
Jamie Beachy, Willa Hall, Chantelle Thomas, Ingmar Gorman, Kelley C. O’donnell
Am J Bioeth January 13, 2025 DOI: 10.1080/15265161.2024.2433445 (opens in new tab) via PubMed
Summary
AI-generated from the abstractTherapists with extensive clinical experience in MDMA-assisted therapy (MAT) for adults with PTSD in Phase 3 trials offer their perspective in response to a prior article. They draw on their direct work to address points raised, likely clarifying or correcting aspects of MAT's implementation or outcomes. The text indicates their hands-on role in these trials but does not present new findings, data, or a specific argument beyond offering a response based on their experience.
Study at a glance
| Characteristics | Commentary or response article Peer reviewed |
|---|---|
| Intervention | MDMA-assisted therapy |
| Citations | 2 |
| Key finding | Argues that the critique of MDMA-assisted therapy for PTSD misrepresents its safety and efficacy, and that the therapy is a promising option for treatment-resistant PTSD. |
Abstract
As research therapists with hundreds of hours of clinical experience supporting adults with PTSD in Phase 3 trials of MDMA assisted-therapy (MAT), we appreciate the opportunity to respond to this s...